These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31986405)

  • 21. Conjugation of a 5-nitrofuran-2-oyl moiety to aminoalkylimidazoles produces non-toxic nitrofurans that are efficacious in vitro and in vivo against multidrug-resistant Mycobacterium tuberculosis.
    Krasavin M; Lukin A; Vedekhina T; Manicheva O; Dogonadze M; Vinogradova T; Zabolotnykh N; Rogacheva E; Kraeva L; Yablonsky P
    Eur J Med Chem; 2018 Sep; 157():1115-1126. PubMed ID: 30179748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, synthesis, and antitubercular evaluation of novel series of 3-benzofuran-5-aryl-1-pyrazolyl-pyridylmethanone and 3-benzofuran-5-aryl-1-pyrazolylcarbonyl-4-oxo-naphthyridin analogs.
    Manna K; Agrawal YK
    Eur J Med Chem; 2010 Sep; 45(9):3831-9. PubMed ID: 20576327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro and in vivo activities of a new lead compound I2906 against Mycobacterium tuberculosis.
    Lu J; Yue J; Wu J; Luo R; Hu Z; Li J; Bai Y; Tang Z; Xian Q; Zhang X; Wang H
    Pharmacology; 2010; 85(6):365-71. PubMed ID: 20530976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antitubercular activities of novel benzothiazolo naphthyridone carboxylic acid derivatives endowed with high activity toward multi-drug resistant tuberculosis.
    Dinakaran M; Senthilkumar P; Yogeeswari P; Sriram D
    Biomed Pharmacother; 2009 Jan; 63(1):11-8. PubMed ID: 18078735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nontoxic Metal-Cyclam Complexes, a New Class of Compounds with Potency against Drug-Resistant Mycobacterium tuberculosis.
    Yu M; Nagalingam G; Ellis S; Martinez E; Sintchenko V; Spain M; Rutledge PJ; Todd MH; Triccas JA
    J Med Chem; 2016 Jun; 59(12):5917-21. PubMed ID: 27214150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 2,4-Dialkyl-8,9,10,11-tetrahydrobenzo[g]pyrimido[4,5-c]isoquinoline-1,3,7,12(2H,4H)-tetraones as new leads against Mycobacterium tuberculosis.
    Claes P; Cappoen D; Uythethofken C; Jacobs J; Mertens B; Mathys V; Verschaeve L; Huygen K; De Kimpe N
    Eur J Med Chem; 2014 Apr; 77():409-21. PubMed ID: 24681334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro and in vivo antimycobacterial activities of ketone and amide derivatives of quinoxaline 1,4-di-N-oxide.
    Villar R; Vicente E; Solano B; Pérez-Silanes S; Aldana I; Maddry JA; Lenaerts AJ; Franzblau SG; Cho SH; Monge A; Goldman RC
    J Antimicrob Chemother; 2008 Sep; 62(3):547-54. PubMed ID: 18502817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Linked pyridinyl-thiadiazoles: Design and synthesis as potential candidate for treatment of XDR and MDR tuberculosis.
    Mahajan NS; Dhawale SC
    Eur J Med Chem; 2015 Sep; 102():243-8. PubMed ID: 26280920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis, and evaluation of novel diphenyl ether derivatives against drug-susceptible and drug-resistant strains of Mycobacterium tuberculosis.
    Kar SS; Bhat VG; Shenoy VP; Bairy I; Shenoy GG
    Chem Biol Drug Des; 2019 Jan; 93(1):60-66. PubMed ID: 30118192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of novel pleuromutilin derivatives. Part 1: preliminary studies of antituberculosis activity.
    Dong YJ; Meng ZH; Mi YQ; Zhang C; Cui ZH; Wang P; Xu ZB
    Bioorg Med Chem Lett; 2015 Apr; 25(8):1799-1803. PubMed ID: 25736994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, synthesis, biological evaluation of substituted benzofurans as DNA gyraseB inhibitors of Mycobacterium tuberculosis.
    Renuka J; Reddy KI; Srihari K; Jeankumar VU; Shravan M; Sridevi JP; Yogeeswari P; Babu KS; Sriram D
    Bioorg Med Chem; 2014 Sep; 22(17):4924-34. PubMed ID: 25129171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of novel antitubercular 1,5-dimethyl-2-phenyl-4-([5-(arylamino)-1,3,4-oxadiazol-2-yl]methylamino)-1,2-dihydro-3H-pyrazol-3-one analogues.
    Ahsan MJ; Samy JG; Jain CB; Dutt KR; Khalilullah H; Nomani MS
    Bioorg Med Chem Lett; 2012 Jan; 22(2):969-72. PubMed ID: 22197387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and Structural Elucidation of Novel Benzothiazole Derivatives as Anti-tubercular Agents: In-silico Screening for Possible Target Identification.
    Venugopala KN; Chandrashekharappa S; Pillay M; Bhandary S; Kandeel M; Mahomoodally FM; Morsy MA; Chopra D; Aldhubiab BE; Attimarad M; Alwassil OI; Harsha S; Mlisana K; Odhav B
    Med Chem; 2019; 15(3):311-326. PubMed ID: 29968540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Benzofuran-isatin hybrids and their in vitro anti-mycobacterial activities against multi-drug resistant Mycobacterium tuberculosis.
    Gao F; Ye L; Wang Y; Kong F; Zhao S; Xiao J; Huang G
    Eur J Med Chem; 2019 Dec; 183():111678. PubMed ID: 31525660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. QSAR-driven design, synthesis and discovery of potent chalcone derivatives with antitubercular activity.
    Gomes MN; Braga RC; Grzelak EM; Neves BJ; Muratov E; Ma R; Klein LL; Cho S; Oliveira GR; Franzblau SG; Andrade CH
    Eur J Med Chem; 2017 Sep; 137():126-138. PubMed ID: 28582669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.
    Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G
    Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis and antitubercular activity of novel N-(amino)piperazinyl benzothiazinones with improved safety.
    Wang A; Du N; Song H; Zhang Y; Zhong X; Wu J; Xue T; Liu M; Wang B; Lv K; Lu Y
    Eur J Med Chem; 2023 Oct; 258():115545. PubMed ID: 37300914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis, and biological evaluation of novel imidazo[1,2-a]pyridinecarboxamides as potent anti-tuberculosis agents.
    Onajole OK; Lun S; Yun YJ; Langue DY; Jaskula-Dybka M; Flores A; Frazier E; Scurry AC; Zavala A; Arreola KR; Pierzchalski B; Ayitou AJ; Bishai WR
    Chem Biol Drug Des; 2020 Dec; 96(6):1362-1371. PubMed ID: 32515129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and in vitro antitubercular evaluation of novel sansanmycin derivatives.
    Li YB; Xie YY; Du NN; Lu Y; Xu HZ; Wang B; Yu Y; Liu YX; Song DQ; Chen RX
    Bioorg Med Chem Lett; 2011 Nov; 21(22):6804-7. PubMed ID: 21982497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and biological evaluation of trans 6-methoxy-1,1-dimethyl-2-phenyl-3-aryl-2,3-dihydro-1H-inden-4-yloxyalkylamine derivatives against drug susceptible, non-replicating M. tuberculosis H37Rv and clinical multidrug resistant strains.
    Kumar S; Dwivedi AP; Kashyap VK; Saxena AK; Dwivedi AK; Srivastava R; Sahu DP
    Bioorg Med Chem Lett; 2013 Apr; 23(8):2404-7. PubMed ID: 23474387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.